Drug details

Creon (pancrelipase capsules)

type of Pancreatic/Digestive Enzymes

Creon (pancrelipase) is a combination of three enzymes: lipase, protease, and amylase, which are normally produced by the pancreas and are important in the digestion of fats, proteins, and sugars, used to replace these enzymes in conditions in which the pancreas is damaged, including cystic fibrosis, chronic inflammation of the pancreas, or blockage of the pancreatic ducts.

The drug is often used to treat Cystic fibrosis .

This drug may have the following side effects:

• nausea,
• headache,
• dizziness,
• vomiting,
• diarrhea,
• constipation,
• stomach pain or upset,
• gas,
• cough, or
• bloating,
• rectal irritation,
• greasy stools,
• weight loss.

The following drugs are related to Creon, either as a replacement or used together:

• Bethkis (tobramycin inhalation solution)
• Creon 10 (pancrelipase delayed-released capsules)
• Creon 20 (pancrelipase delayed-released capsules)
• Creon 5 (pancrelipase delayed-release minimicrospheres)
• Levsin (hyoscyamine)
• Levsin SL (hyoscyamine sulfate tablets)
• Kitabis Pak (tobramycin inhalation solution for oral inhalation)
• Pancreaze (pancrelipase microtablets)
• Tobi (tobramycin)
• TOBI Podhaler (tobramycin inhalation powder)